STOCKWATCH
·
Pharmaceuticals
Acquisitions12 Jul 2025, 06:51 pm

Zydus Lifesciences Ltd Incorporates Zylidac Bio LLC in the USA for Acquisition of Agenus Biologics Facilities

AI Summary

Zydus Lifesciences Ltd, through its wholly owned subsidiary Zydus Pharmaceuticals USA Inc., has incorporated a new wholly owned subsidiary, Zylidac Bio LLC, in the United States of America. The new subsidiary is set to acquire two U.S. based biologics manufacturing facilities of Agenus, one in Emeryville, CA and another in Berkeley, CA. Zylidac Bio LLC is a pharmaceutical company with no initial share capital and is yet to commence its business operation.

Key Highlights

  • Zydus Lifesciences Ltd incorporates a new subsidiary, Zylidac Bio LLC, in the USA
  • Zylidac Bio LLC to acquire two Agenus biologics manufacturing facilities in California
  • Zylidac Bio LLC is a wholly owned subsidiary of Zydus Pharmaceuticals USA Inc.
  • Zylidac Bio LLC is a pharmaceutical company with no initial share capital
  • Zylidac Bio LLC is yet to commence its business operation
ZYDUSLIFE
Pharmaceuticals
Zydus Lifesciences Ltd

Price Impact